 |
|
Upcoming Events featuring
National CooperativeRx
|
|
|
RASHRM Annual Conference
October 16, 2012
Rockford, IL
Learn more
|
|
 |
National CooperativeRx is a not-for-profit coalition founded and owned by plan sponsors to achieve higher value prescription benefits through volume purchasing, clinical solutions, actionable data and unparalleled customer service. For your sales and marketing needs, please contact us at 866-679-9479, extension 223
|
|
|
Welcome to Pharmacy Month
October is Pharmacy Month! National CooperativeRx is celebrating pharmacy month with a lot of great information regarding drug safety for both you and your participants.
First of all, THANK YOU to all of our members, agents and brokers who were able to attend this week's Antibiotic Resistance webinar. We appreciate the opportunity to share these educational opportunities with you, and hope you were able to walk away with valuable information.
During the webinar, we discussed how using antibiotics for viral infections can cause more harm than good. Did you know that antibiotic resistance is becoming a bigger issue worldwide, with diseases such as tuberculosis and gonorrhea growing more resistant to antibiotics? To learn more about antibiotic resistance, click here.
|
|
Health. Weight loss surgery, specifically gastric bypass, has been linked to an increased risk for alcohol and drug abuse. Theories behind this are that patients switch their food addiction to an alcohol addiction, or they feel intoxicated sooner due to their lower weight and therefore enjoy drinking more. A third theory is that as weight is shed, people become more social and use alcohol and drugs to relax more in social settings. (Mann, 10/15) Full story
|
|
HealthDay. An increasing number of women are using IUDs and other longer-term birth control than in the past. While the pill and sterilization are still more common forms of birth control, use of the IUD has increased from 1% up to almost 6% since 1995. Use of the patch and the ring has also increased. (10/18) Full story
|
Chicago Tribune. GlaxoSmithKline is planning on releasing detailed data from clinical trials to other researchers. Opening up it's data will help in the discovery of new drugs and also allow outside researchers to discover genuine problems with drugs. It will also allow researchers to review drug compounds that might help with diseases such as TB that have a need for treatment, but are neglected because they aren't going to be big money-makers. (Hirschler, 10/11) Full Story
|
ABC News. This year's Chemistry Nobel Prize winners may be helping the pharmaceutical industry to develop future drugs with fewer side effects. Dr. Robert Lefkowitz and Brian Kobilka won the prize "for work on a family of proteins embedded in cell walls that detect the presence of a hormone such as adrenaline outside a cell." (Spotts, 10/13) Full Story
|
LA Times. The fungal meningitis outbreak that is responsible for 14 deaths has highlighted a problem in the pharmaceutical industry, and put the issue in front of the FDA. While pharmaceutical companies are heavily regulated, compound pharmacies are not, and it was a compound pharmacy responsible for the tainted medications. Meant to be a small, specialized pharmacy, some of these businesses have grown to become large manufacturing companies. (10/12) Full Story
|
The New York Times. In the past 3 years, 6 major injectable drug makers have been warned by the FDA that they were violating manufacturing rules. Four of them had to close down or slow their manufacturing to address the violations, leading to some of the recent drug shortages the US has experienced. This article examines the shape of drug manufacturing factories in the US. (Thomas, 10/17) Full Story
|
|
 |
|
